{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:01:40Z","timestamp":1775898100819,"version":"3.50.1"},"reference-count":37,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2022.13493","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T07:01:23Z","timestamp":1662361283000},"source":"Crossref","is-referenced-by-count":4,"title":["Prognostic implications of immune classification using IDO1 expression in extrahepatic bile duct carcinoma"],"prefix":"10.3892","volume":"24","author":[{"given":"Byeong-Joo","family":"Noh","sequence":"first","affiliation":[{"name":"Department of Pathology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon\u2011do 25440, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon\u2011do 25440, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon\u2011do 25440, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon\u2011do 25440, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Suk","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon\u2011do 25440, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moonho","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon\u2011do 25440, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Woon","family":"Eom","sequence":"additional","affiliation":[{"name":"Department of Pathology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Gangwon\u2011do 25440, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"key20220923112701_b1-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1200\/EDBK_160831","article-title":"Biliary tract cancer: Epidemiology, radiotherapy, and molecular profiling","volume":"35","author":"Bridgewater","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20220923112701_b2-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"key20220923112701_b3-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: A single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann Surg"},{"key":"key20220923112701_b4-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.3390\/cancers12082190","article-title":"Molecular and immunological characterization of biliary tract cancers: A paradigm shift towards a personalized medicine","volume":"12","author":"Malenica","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20220923112701_b5-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40425-019-0691-0","article-title":"miR-448 targets IDO1 and regulates CD8(+) T cell response in human colon cancer","volume":"7","author":"Lou","year":"2019","journal-title":"J Immunother Cancer"},{"key":"key20220923112701_b6-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3109\/08820139.2012.676122","article-title":"Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity","volume":"41","author":"Harden","year":"2012","journal-title":"Immunol Invest"},{"key":"key20220923112701_b7-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40425-015-0094-9","article-title":"Targeting the indoleamine 2,3-dioxygenase pathway in cancer","volume":"3","author":"Moon","year":"2015","journal-title":"J Immunother Cancer"},{"key":"key20220923112701_b8-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejca.2017.01.011","article-title":"The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy","volume":"76","author":"Brochez","year":"2017","journal-title":"Eur J Cancer"},{"key":"key20220923112701_b9-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"key20220923112701_b10-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000492849","article-title":"The clinicopathological and prognostic significance of IDO1 expression in human solid tumors: Evidence from a systematic review and meta-analysis","volume":"49","author":"Yu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"key20220923112701_b11-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","article-title":"Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase","volume":"196","author":"Frumento","year":"2002","journal-title":"J Exp Med"},{"key":"key20220923112701_b12-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00262-013-1393-y","article-title":"Analysis of indoleamine 2\u20133 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry","volume":"62","author":"Soliman","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"key20220923112701_b13-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1158\/1078-0432.CCR-07-0942","article-title":"Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma","volume":"13","author":"Riesenberg","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20220923112701_b14-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6603477","article-title":"Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer","volume":"95","author":"Ino","year":"2006","journal-title":"Br J Cancer"},{"key":"key20220923112701_b15-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1479-5876-7-71","article-title":"The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer","volume":"7","author":"Gao","year":"2009","journal-title":"J Transl Med"},{"key":"key20220923112701_b16-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ygyno.2010.02.028","article-title":"Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy","volume":"117","author":"Inaba","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20220923112701_b17-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-012-1340-x","article-title":"Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma","volume":"462","author":"Ye","year":"2013","journal-title":"Virchows Arch"},{"key":"key20220923112701_b18-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijc.25979","article-title":"High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma","volume":"130","author":"Jacquemier","year":"2012","journal-title":"Int J Cancer"},{"key":"key20220923112701_b19-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1440-1746.2003.03259.x","article-title":"Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma","volume":"19","author":"Ishio","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"key20220923112701_b20-ol-24-04-13493","first-page":"317","article-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017","edition":"8th edition"},{"key":"key20220923112701_b21-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/bjc.2011.513","article-title":"Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer","volume":"106","author":"Ferdinande","year":"2012","journal-title":"Br J Cancer"},{"key":"key20220923112701_b22-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7150\/jca.27507","article-title":"High expression of indoleamine 2, 3-dioxygenase in adenosquamous lung carcinoma correlates with favorable patient outcome","volume":"10","author":"Ma","year":"2019","journal-title":"J Cancer"},{"key":"key20220923112701_b23-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/sj.bjc.6605318","article-title":"CD8+ lymphocytes\/tumour-budding index: An independent prognostic factor representing a \u2018pro-\/anti-tumour\u2019 approach to tumour host interaction in colorectal cancer","volume":"101","author":"Lugli","year":"2009","journal-title":"Br J Cancer"},{"key":"key20220923112701_b24-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jso.10321","article-title":"Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response","volume":"84","author":"Oshikiri","year":"2003","journal-title":"J Surg Oncol"},{"key":"key20220923112701_b25-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/00006676-200401000-00023","article-title":"CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma","volume":"28","author":"Fukunaga","year":"2004","journal-title":"Pancreas"},{"key":"key20220923112701_b26-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"key20220923112701_b27-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","article-title":"Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer","volume":"29","author":"Mahmoud","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20220923112701_b28-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","article-title":"Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction","volume":"29","author":"Mlecnik","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20220923112701_b29-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/bjc.2017.401","article-title":"Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma","volume":"118","author":"Kitano","year":"2018","journal-title":"Br J Cancer"},{"key":"key20220923112701_b30-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1038\/bjc.2013.610","article-title":"Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer","volume":"109","author":"Goeppert","year":"2013","journal-title":"Br J Cancer"},{"key":"key20220923112701_b31-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: Effect on tumor-infiltrating T cells","volume":"12","author":"Brandacher","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20220923112701_b32-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: Inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"key20220923112701_b33-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"key20220923112701_b34-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.180.2.489","article-title":"Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection","volume":"180","author":"Maggi","year":"1994","journal-title":"J Exp Med"},{"key":"key20220923112701_b35-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/genes12020273","article-title":"High PD-L1\/IDO-2 and PD-L2\/IDO-1 Co-expression levels are associated with worse overall survival in resected non-small cell lung cancer patients","volume":"12","author":"Ludovini","year":"2021","journal-title":"Genes (Basel)"},{"key":"key20220923112701_b36-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41379-018-0160-1","article-title":"Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas","volume":"32","author":"Zhang","year":"2019","journal-title":"Mod Pathol"},{"key":"key20220923112701_b37-ol-24-04-13493","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 inhibitors: From bench to bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T08:33:10Z","timestamp":1663921990000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,9,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2022.13493","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"article-number":"373"}}